You need to enable JavaScript to run this app.
FDA details approach for finding optimal dosages for new cancer drugs
Regulatory News
Joanne S. Eglovitch
Biologics
Clinical Trials
North America
Pharmaceuticals
Regulatory Intelligence/Policy